The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling

Olga Ananieva1, Joanne Darragh, Claus Johansen

  • 1Medical Research Council Protein Phosphorylation Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK.

Nature Immunology
|August 12, 2008
PubMed

Insights

Mitogen-activated protein kinase-activated protein kinase 1 (MSK1) and MSK2 limit inflammatory cytokine production. These kinases are crucial for negative feedback in Toll-like receptor-driven inflammation.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • Mitogen-activated protein kinases (MAPKs) like p38 and Erk1/2 are key signaling molecules.
  • MSK1 and MSK2 are kinases activated downstream of p38 and Erk1/2.
  • Toll-like receptor (TLR) signaling initiates inflammatory responses.

Purpose of the Study:

  • To investigate the role of MSK1 and MSK2 in regulating inflammatory responses.
  • To elucidate the molecular mechanisms by which MSK1 and MSK2 control cytokine production.
  • To determine the in vivo significance of MSK1 and MSK2 in inflammatory models.

Main Methods:

  • Primary macrophage stimulation with lipopolysaccharide (LPS).
  • Analysis of gene transcription, including DUSP1 and IL-10.
  • Assessment of transcription factor binding to gene promoters.
  • In vivo studies using MSK1 and MSK2 deficient mice in endotoxic shock and contact eczema models.

Main Results:

  • MSK1 and MSK2 are essential for limiting pro-inflammatory cytokine production following LPS stimulation.
  • MSK1 and MSK2 induce transcription of DUSP1 and IL-10, acting as negative feedback regulators.
  • MSK1/MSK2 deficiency impairs CREB and ATF1 binding to IL-10 and DUSP1 gene promoters.
  • MSK1/MSK2 deficient mice exhibit heightened sensitivity to LPS-induced endotoxic shock and prolonged inflammation.

Conclusions:

  • MSK1 and MSK2 are critical negative feedback components in TLR-driven inflammatory pathways.
  • These kinases play a vital role in controlling the magnitude and duration of inflammatory responses.
  • Targeting MSK1/MSK2 could offer therapeutic strategies for inflammatory diseases.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...